Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04381390 · ClinicalTrials.gov registry record · NA

Egg Consumption and Muscular Adaptations

A NA study of Hypertrophy, sponsored by Alexei Wong.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04381390: Completed NA study of Hypertrophy, sponsored by Alexei Wong.

NCT04381390 is a NA study of Hypertrophy that has completed, run by Alexei Wong. The registered enrollment target is 30 participants, roughly in line with the 31-participant average among 4 other Hypertrophy trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04381390, a NA study of Hypertrophy, has completed, sponsored by Alexei Wong.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Eggs may be a viable alternative to various types of supplemental proteins given its similar ratings on various measures of dietary protein quality. The investigators hypothesis is that whole eggs would create a greater improvement in skeletal regulatory markers, hormonal responses and body composition than egg white ingestion in resistance-trained men.

Primary Outcome

Fasting blood samples were collected from the antecubital vein using standard procedures and then analized to establish concentration of myostatin, follistatin, FGF-2, TGF-β1 and ACVA.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Whole egg and resistance training
  • DIETARY_SUPPLEMENT Egg whites and resistance training

Study Locations (1)

Virginia

  • Marymount University - Arlington

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2018-09-10
Est. Completion 2019-10-02
Phase NA
Alexei Wong

1 total trials

What the finished NCT04381390 record still lists

NCT04381390 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, roughly in line with the 31-participant average among 4 other Hypertrophy trials with a reported enrollment target.

The record links to 1 condition, with Hypertrophy appearing as the primary indexed condition, and to 2 interventions - of which Whole egg and resistance training is the first listed.

NCT04381390 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT04381390 about?

NCT04381390 is a clinical study titled "Egg Consumption and Muscular Adaptations". Eggs may be a viable alternative to various types of supplemental proteins given its similar ratings on various measures of dietary protein quality. The investigators hypothesis is that whole eggs would create a greater improvement in skeletal regulatory markers, hormonal responses and body composi...

What is the current status of trial NCT04381390?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-09-10. Estimated completion is 2019-10-02.

What conditions does trial NCT04381390 study?

This clinical trial studies the following conditions: Hypertrophy.

What interventions are being tested in trial NCT04381390?

The interventions under investigation include: Whole egg and resistance training (DIETARY_SUPPLEMENT), Egg whites and resistance training (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04381390?

This trial is sponsored by Alexei Wong, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04381390 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertrophy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04381390, the US trial registry maintained by the National Library of Medicine. NCT04381390 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.